Hytn Innovations Inc. Stock
€0.17
Your prediction
Financial data and news for Hytn Innovations Inc.
sharewise wants to provide you with the best news and tools for Hytn Innovations Inc., so we directly link to the best financial data sources.
Financials
News
HYTN Partners with the UK's 4C Labs, Validates GMP Certification
Vancouver, British Columbia - September 10th, 2024 - HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the
HYTN Lists on the OTC Pink Market
Vancouver, British Columbia – July 29th, 2024 - HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0 | OTC PINK: HYTNF) “HYTN” or “the Company”, a pharmaceutical company specializing in the
HYTN Awarded Drug Establishment License from Health Canada, Expanding GMP Capabilities
"One of the very few companies globally to achieve these certifications"
Vancouver, British Columbia – June 27th, 2024 - HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) “HYTN” or “The
HYTN Welcomes U.S. Recommendation to Reclassify Cannabis, Foresees Growth
Vancouver, British Columbia – May 01, 2024 – HYTN Innovations Inc. (CSE: HYTN “HYTN” or “The Company”), a leader in the development, formulation, and manufacturing of products containing
HYTN Innovates GMP Stability Programs, Sets Industry Benchmark
Vancouver, British Columbia – April 22, 2024 - HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) “HYTN” or “The Company”, a leader in the development, formulation, and manufacturing of products
HYTN Welcomes Health Canada for Audit to Enhance GMP Capabilities
Vancouver, British Columbia – April 9, 2024 - HYTN Innovations Inc. (CSE: HYTN, “HYTN” or “The Company”), a leader in the development, formulation, and manufacturing of products containing
HYTN Provides Corporate Update, Outlines New Global Direction
One of the only Canadian firms meeting the stringent specifications of both the German Pharmacopoeia and European Pharmacopoeia for Cannabis Flower
Vancouver, British Columbia – April 3,